Mechanism Studies of Antitubulin Agents-mediated MMP Down-regulation and Nitroxoline Repurposing in Human Prostate Cancer Cells

Wei‐Ling Chang(Hong Kong Polytechnic University)

OhioLink ETD Center (Ohio Library and Information Network)

May 22, 2015

Cited by 0

Related Papers

The Making of a Flight Feather: Bio-architectural Principles and Adaptation

|Cell|2019|61

Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer - a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation

|Oncotarget|2015|49

2‐Phenyl‐5‐(pyrrolidin‐1‐yl)‐1‐(3,4,5‐trimethoxybenzyl)‐1 <i>H</i> ‐benzimidazole, a benzimidazole derivative, inhibits growth of human prostate cancer cells by affecting tubulin and c‐Jun N‐terminal kinase

|British Journal of Pharmacology|2010|28